5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseasesinterstitial lung disease, lung disorder, respiratory system disorderActive, not recruitingPhase 32026-10-02NCT06806592
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progressioninterstitial lung disease, lung disorder, respiratory system disorderRecruitingPhase 32026-10-01NCT07540988
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilastidiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderActive, not recruitingPhase 32026-09-30NCT06238622
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related ThrombocytopeniaCytopenia, Hemic and Lymphatic Diseases, blood platelet disease, hematologic disorder, thrombocytopeniaRecruitingPhase 42026-06-30NCT06722586
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)Acute Ischemic Stroke, Anterior Circulation Brain Infarction, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 32025-12-10NCT06559241